⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

Official Title: A Randomized, Double-blind, Placebo-controlled, Phase III Clinical Trial of GB491 Combined With Fulvestrant in Subjects With HR+, HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed on Prior Endocrine Therapy

Study ID: NCT05054751

Study Description

Brief Summary: GB491-004 is a multicenter, randomized, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of GB491 in combination with fulvestrant in patients with HR-positive, HER2-negative locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China

Anhui Provincial Cancer Hospital, Hefei, Anhui, China

The Second Hospital of Anhui Medical University, Hefei, Anhui, China

Beijing Chaoyang Hospital of Capital Medical University, Beijing, Beijing, China

Cancer hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China

Chinese PLA General Hospital, Beijing, Beijing, China

Beijing Tiantan Hospital , Capital Medical University, Beijing, Beijing, China

Chongqing University Cancer Hospital, Chongqing, Chongqing, China

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China

Chognqing University Three Gorges Hospital, Chongqing, Chongqing, China

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

The First people's hospital of Foshan, Foshan, Guangdong, China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Guangdong provincial TCM hospital, Guangzhou, Guangdong, China

Meizhou People's Hospital, Meizhou, Guangdong, China

Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center Shenzhen Cancer Hospital, Shenzhen, Guangdong, China

Hainan General Hospital, Haikou, Hainan, China

Hainan Third People's Hospital, Sanya, Hainan, China

The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Affiliated hospital of Hebei University, Shijiazhuang, Hebei, China

Harbin Medcial Univercity cancer hospital, Haerbin, Heilongjiang, China

Henan Cancer Hospital, Zhengzhou, Henan, China

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

Renmin Hospital of Wuhan University, Wuhan, Hubei, China

Hubei Cancer Hospital, Wuhan, Hubei, China

The Affiliated hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China

Jiangsu Province Hospital, Nanjing, Jiangsu, China

Jiangxi Provincial Hospital, Nanchang, Jiangxi, China

Jilin Cancer Hospital, Changchun, Jilin, China

The Second Hospital of Jilin University, Changchun, Jilin, China

Bethune First Hospital Of Jilin University, Changchun, Jillin, China

Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

Liaoning Cancer hospital & Institute, Shenyang, Liaoning, China

General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China

Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China

Shandong Provincial Hospital, Jinan, Shandong, China

Shandong Cancer Hospital, Jinan, Shandong, China

Affiliated hospital of Jining Medical University, Jining, Shandong, China

Liaocheng People's Hospital, Liaocheng, Shandong, China

The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Taian City Central Hospital, Taian, Shandong, China

Yantai Yuhuangding Hospital, Yantai, Shandong, China

Zhongshan Hospital Fudan University, Shanghai, Shanghai, China

The first hospital of Shanxi Medical University, Taiyuan, Shanxi, China

West China School of Medicine, Chengdu, Sichuan, China

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China

Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China

The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Contact Details

Name: Binghe Xu, PhD

Affiliation: Chinese Academy of Medical Sciences

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: